A subsequent study by Li et al. evaluating POTS patients demonstrated the presence of activating β1AR AAbs in all 14 patients and of β2AR autoantibodies in 7 of 14 patients. This evidence concerns the gene ADRB2 and postural orthostatic tachycardia syndrome.